+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors for community-acquired infections caused by extended-spectrum beta-lactamase-producing Escherichia coli



Risk factors for community-acquired infections caused by extended-spectrum beta-lactamase-producing Escherichia coli



Archives of Internal Medicine 169(8): 811; Author Reply 811-2




(PDF emailed within 0-6 h: $19.90)

Accession: 055580750

Download citation: RISBibTeXText

PMID: 19398696

DOI: 10.1001/archinternmed.2009.97


Related references

Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum beta-Lactamase-Producing Escherichia coli Strains. 2012

Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Journal of ChemoTherapy 20(5): 581-585, 2008

Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species. Investigative and Clinical Urology 60(1): 46-53, 2019

Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clinical Microbiology and Infection 14(2): 180-183, 2007

Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains. Journal of Clinical Microbiology 50(2): 312-317, 2012

Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. International Journal of Clinical Practice 69(7): 766-770, 2016

Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Journal of Clinical Microbiology 48(5): 1726-1731, 2010

Mecillinam/clavulanate combination a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. 2012

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. International Journal of Antimicrobial Agents 36(3): 284-287, 2010

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Archives of Internal Medicine 168(17): 1897-1902, 2008

Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrobial Agents and ChemoTherapy 52(9): 3244-3252, 2008

Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clinical Microbiology and Infection 16(2): 147-151, 2010

Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy. Scandinavian Journal of Infectious Diseases 45(7): 519-525, 2013

Potential role of fosfomycin in the treatment of community-acquired lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. American Journal of Therapeutics 20(6): 685-690, 2014

Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli. Journal of Microbiology, Immunology, and Infection 43(4): 310-316, 2010